Primiano Christopher Brett has been a registered insider since 2003.
As a General Counsel at Karyopharm Therapeutics, Primiano Christopher Brett last made a transaction on 12/1/2020.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 1 |
100% |
11% |
-- |
-- |
1 Year |
1 |
0% |
-- |
-- |
-- |
| 1 |
100% |
1% |
-- |
-- |
9 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
100% |
63% |
-- |
-- |
6 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
100% |
42% |
-- |
-- |
3 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
0% |
-8% |
-- |
-- |
1 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
0% |
-1% |
-- |
-- |
1 Week |
1 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 20 |
70% |
-21% |
-36% |
190 |
1 Year |
20 |
0% |
-- |
-- |
-- |
| 20 |
75% |
-6% |
-22% |
164 |
9 Month |
20 |
0% |
-- |
-- |
-- |
| 20 |
55% |
0% |
-2% |
159 |
6 Month |
20 |
0% |
-- |
-- |
-- |
| 20 |
40% |
4% |
2% |
122 |
3 Month |
20 |
0% |
-- |
-- |
-- |
| 20 |
45% |
-2% |
2% |
60 |
1 Month |
20 |
0% |
-- |
-- |
-- |
| 20 |
50% |
-0% |
0% |
32 |
1 Week |
20 |
0% |
-- |
-- |
-- |
| Scorecards Updated 6/9/2023 12:45 AM EST |
Latest Transaction Date: |
12/1/2020 |
| Average days between Transaction and Entered Dates: |
3 |
